Hong Kong Authorities Warn Public Against Three Weight-Loss Drugs
This article was originally published in PharmAsia News
Executive Summary
Hong Kong's health department issued a warning to the healthcare community about adverse effects from drugs containing orlistat, the active pharmaceutical ingredient in three weight-loss treatments